Enzene Biosciences
India · $412.0M raised
- Business Model
- B2B Services
- Website
- enzene.com
- Total Funding
- $412.0M
- Last Round
- $362.0M Private EquityDec 2025
- Rounds
- 2
About
Global biologics CDMO specializing in biosimilars development, manufacturing, and continuous bioprocess solutions.
Summary
Enzene Biosciences is a Biotech company based in India. It has raised $412.0M in total across 2 rounds, most recently a $362.0M Private Equity round in Dec 2025. Investors include Alkem Laboratories, Eight Roads Ventures and F-Prime Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.